Establishing an 8‐gene immune prognostic model based on TP53 status for lung adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24538
Abstract: Lung adenocarcinoma (LUAD) results in a majority of cancer burden worldwide. TP53 is the most commonly mutated in LUAD. This study aimed to reveal the relation between TP53 and tumor microenvironment (TME) for improving LUAD… read more here.
Keywords: immune prognostic; lung adenocarcinoma; gene immune; establishing gene ... See more keywords